Esthetic reconstruction after mastectomy for inflammatory breast cancer: is it worthwhile?1
| Autor: | David Chu, Joshua D. I. Ellenhorn, Philip L. Chin, James S. Andersen, George Somlo, Roderich E. Schwarz |
|---|---|
| Rok vydání: | 2000 |
| Předmět: |
medicine.medical_specialty
education.field_of_study business.industry medicine.medical_treatment Population medicine.disease Inflammatory breast cancer Surgery Radiation therapy Plastic surgery Breast cancer Medicine skin and connective tissue diseases business Breast reconstruction education Survival rate Mastectomy |
| Zdroj: | Journal of the American College of Surgeons. 190:304-309 |
| ISSN: | 1072-7515 |
| DOI: | 10.1016/s1072-7515(99)00267-7 |
| Popis: | Background: Because inflammatory breast cancer (IBC) has been viewed as a malignancy with a poor likelihood of longterm survival, few women have been offered esthetic reconstruction after mastectomy for IBC. Recent advances in multimodality therapy have improved the outcomes for women with this disease. The purpose of this review was to assess the results of esthetic breast reconstruction in the population with IBC. Study Design: Review of medical records at the City of Hope National Medical Center for the 10-year period ending in May 1997, revealed 23 women who underwent elective esthetic breast reconstruction after mastectomy for IBC. The records of these patients were reviewed retrospectively. Patients requiring reconstruction for large surgical chest wall defects were not included in the review. Results: Treatment for IBC included mastectomy in all patients, chemotherapy in 22, and chest wall radiation therapy in 14. Immediate reconstruction was performed at the time of mastectomy (n = 14) or was delayed (n = 9). The types of reconstruction included transverse rectus abdominis musculocutaneous flap (n = 18), latissimus dorsi flap (n = 2), or prosthetic mammary implant reconstruction (n = 3). Seven women chose to undergo additional reconstruction procedures (ie, nipple reconstruction) after their initial reconstruction. With a median followup of 44 months for survivors, 16 patients developed recurrence after reconstruction. Of these, 6 were local recurrences and 10 were distant failures. Seven patients are currently alive with no evidence of disease, 4 are currently alive with disease, and 12 have died as a result of breast cancer. The median disease-free survival after reconstruction was 19 months. The median overall survival after reconstruction for all patients was 22 months. The only negative predictor of survival was a positive surgical margin at mastectomy. Conclusions: The significant emotional and esthetic benefits of breast reconstruction should be available to women with IBC. In light of the improving prognosis of IBC with current aggressive multimodality treatment, reconstructive procedures should be offered as part of comprehensive therapy. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|